NEWARK, Del, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The global 3D printed drugs market is expected to reach a valuation of US$ 742.88 Mn in 2032, with the market expanding at a stellar CAGR of 9.2% from 2022 to 2032. The target market will likely generate an estimated US$ 307.54 Mn by the end of 2022. Large-scale applications in the healthcare sector along with the rise of chronic ailments fuel the growth of the 3D printed drugs market during the forecast period.
Quick solubility and customizable aspect of 3D printed drugs augments the demand for the same in the international market. These drugs are produced by the help of powder bed inkjet printing by adding the drug's components in a layer by layer format- similar to 3D printing for any other application. This process of production makes the medications easier to swallow and is advantageous for people suffering from dysphagia.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2336
Moreover, 3D printing has the potential to fasten up the arrival of customized pharmaceuticals or the development of therapeutic blends. With the help of 3D printing, medications could be personalized for each patient, which will likely be more effective than batch-produced medications as they would be produced individually with consideration for that patient's medical history. All of these considerations aid the growth of the 3D printed drugs market during the forecast period.
“A surge in the demand for customized medications will fuel the global growth of the 3D printed drugs market over the forecast period,” says an FMI analyst.
Key Takeaways:
- The inkjet printer technology segment will hold 24% of the 3D printed drugs market share by the end of 2022.
- The hospitals and clinics end-user segment will own about 45% of the overall market share.
- In 2022, the 3D printed drugs market in North America will account for 31.1% of the total market share.
- Europe’s 3D drug printing market will hold 29.9% of the market share in 2022.
- Immense potential for 3D printed drugs research will drive the Asia Pacific market to hold 27% of the overall market share in 2022.
Competitive Landscape
Hewlett Packard Caribe, Merck, Cycle Pharmaceuticals, AstraZeneca, Aprecia, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC Extend Biosciences, Bioduro, Affinity Therapeutics, GlaxoSmithKline Plc, and FabRx Ltd. among others are some of the major players in the 3D printed drugs market profiled in the full version of the report.
Key market players are focusing on product development and new product launches to meet the growing demand. These organizations also employ strategic partnership and collaboration tactics to gain a competitive advantage.
Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2336
More Insights into 3D Printed Drugs Market Report
In its latest report, FMI offers an unbiased analysis of the global 3D printed drugs market, providing historical data from 2017 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of the dosage form (3D printed tablets, 3D printed capsules, 3D printed multi drug implants, 3D printed nanoparticles, 3D printed solutions, other 3D printed drug dosage forms), technology (inkjet 3D printed drugs, direct write 3D printed drugs, zip dose 3D printed drugs, thermal inkjet 3D printed drugs, 3D printed drugs based on fuel deposition modeling, powder bed 3D printed drugs, stereo lithography (SLA) 3D printed drugs, semi solid extrusion (SSE) 3D printed drugs), and region.
According to the latest FMI reports, based on segmentation, the inkjet printer technology will gain momentum over the forecast period. This segment will likely account for 24% of the 3D printed drugs market share in 2022. Owing to technological advancement the inkjet printers are easier and convenient to use. In terms of end use, hospitals and clinics are expected to be major contributors to the overall growth of the target market As easy installation and fewer waste fasten up the manufacture of 3D printed drugs in hospitals and clinics, these end users are predicted to hold 45% of the overall market share.
Based on region, the 3D printed drugs market in North America will exhibit impressive growth during 2022-2032. Increasing incidences of chronic diseases, an aging population, access to a well-established healthcare infrastructure are some of the factors that drive the target market in this region. Thus, the 3D printed drugs market in North America will account for 31.1% of the total market share in 2022. Besides North America, Europe and the Asia Pacific regions, too, will register considerable 3D printed drugs market growth during the forecast period.
Ask the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-2336
Key Segments Covered in the 3D Printed Drugs Industry Analysis
3D Printed Drugs Market by Dosage Form:
- 3D Printed Tablets
- 3D Printed Capsules
- 3D Printed Multi Drug Implants
- 3D Printed Nanoparticles
- 3D Printed Solutions
- Other 3D Printed Drug Dosage Forms
3D Printed Drugs Market by Technology:
- Inkjet 3D Printed Drugs
- Direct Write 3D Printed Drugs
- Zip Dose 3D Printed Drugs
- Thermal Inkjet 3D Printed Drugs
- 3D Printed Drugs based on Fused Deposition Modeling
- Powder Bed 3D Printed Drugs
- Stereo Lithography (SLA) 3D Printed Drugs
- Semi Solid Extrusion (SSE) 3D Printed Drugs
3D Printed Drugs Market by Region:
- North America 3D Printed Drugs Market
- Latin America 3D Printed Drugs Market
- Europe 3D Printed Drugs Market
- Asia Pacific 3D Printed Drugs Market
- Middle East & Africa 3D Printed Drugs Market
Report Preview@ https://www.futuremarketinsights.com/reports/3d-printed-drugs-market
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
Toc to be continued…
Have a Look at Research Reports of the Healthcare Domain
General Anesthesia Drugs Market: is expected to enjoy a valuation of US$ 4.7 Bn by the end of the year 2022, and further expand at a CAGR rate of 3.4% to reach a valuation of US$ 6.7 Bn by the year 2032.
Injectable Drugs Market: is expected to reach US$ 531.8 Bn in 2022. Sales in the market will increase at a CAGR of 5.8%, reaching US$ 937.0 Bn by 2032.
Critical Care Patient Monitoring Products Market: is expected to grow at a CAGR of 8.6%.
Cardiac Biomarker Diagnostic Test Kits Market: is projected to expand at 5.1% CAGR over the forecast period, from 2022 to 2028.
Cardiac Assist Devices Market: is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Bn by 2031.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
Enquiries: sales@futuremarketinsights.com
